Form 4: Pulse Biosciences Director Zanganeh Exercises Rights Offering, Acquires Shares and Warrants

Director Mahkam Zanganeh acquired Pulse Biosciences common stock and warrants through the exercise of subscription rights in a previously announced rights offering.

Summary

• Director Mahkam Zanganeh acquired 60,242 shares of Pulse Biosciences common stock on July 3, 2024.
• The acquisition was made through the exercise of subscription rights in connection with the Issuer's previously announced rights offering.
• Zanganeh also acquired warrants to purchase 30,121 shares of common stock at an exercise price of $11.00 per whole share.
• The purchase price was $10.00 per unit, with each unit consisting of one share of common stock and two warrants each to purchase one half share of common stock.
• Following the transaction, Zanganeh directly owns 30,121 warrants and indirectly owns 27,000 shares through an immediate family member, 14,000 shares through another immediate family member, and 107,074 shares through another immediate family member.

Sentiment

Score: 7

Explanation: Insider participation in a rights offering is generally a positive signal, suggesting confidence in the company's future. However, the document itself is simply a regulatory filing and doesn't provide extensive information to gauge overall sentiment.

Positives

• The director's participation in the rights offering demonstrates confidence in the company's future.

Future Outlook

The document does not contain specific forward-looking statements beyond the terms of the rights offering.

Industry Context

Rights offerings are a common method for companies, particularly in the biotech sector, to raise capital. Insider participation is generally viewed positively by the market.

Comparison to Industry Standards

• Insider participation in rights offerings is a common practice in the biotech industry.
• Companies like CRISPR Therapeutics and Editas Medicine have also used rights offerings to raise capital, with varying degrees of insider participation.
• The level of insider participation is often seen as a signal of management's confidence in the company's prospects.

Stakeholder Impact

• The director's participation in the rights offering could be viewed positively by shareholders.

Key Dates